About
Synthetic oligonucleotides vaccines, adjuvants
Areas of Focus
Categories
VaccineGene Therapy, RNA & Peptide TherapyBiotech
Clinical Trials (30)
View allTotal Trials
30
As Lead Sponsor
25
As Collaborator
5
Total Enrollment
17,943
By Phase
PHASE2: 7PHASE1/PHASE2: 3PHASE1: 11PHASE3: 6NA: 1
By Status
COMPLETED: 21TERMINATED: 5RECRUITING: 2UNKNOWN: 1WITHDRAWN: 1
Clinical Trials Pipeline30 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07207408Lead Sponsor
Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age
PHASE2Recruiting
148 participants
Started: Sep 11, 2025 · Completed: Oct 16, 2026
NCT06569823Lead Sponsor
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults
PHASE1/PHASE2Recruiting
440 participants
Started: Jun 17, 2024 · Completed: Sep 30, 2026
NCT05506969Lead Sponsor
Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age
PHASE2Completed
200 participants
Started: Aug 9, 2022 · Completed: Apr 26, 2024
NCT05245838Lead Sponsor
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers
PHASE1Completed
150 participants
Started: Jan 10, 2022 · Completed: Oct 20, 2022
NCT03664648Lead Sponsor
DV2-HBV-27: Observational Pregnancy Registry
N/AUnknown
300 participants
Started: Feb 21, 2021 · Completed: Dec 31, 2024
Locations (1)
Headquarters
Emeryville, CA, United States
Map
Loading map...